Shares of Organigram (OGI) opened at C$4.31 on Wednesday. Organigram has a 1-year low of C$1.95 and a 1-year high of C$5.68. The company has a market cap of $526.95, a price-to-earnings ratio of -39.18 and a beta of 8.35.
Organigram (CVE:OGI) last posted its quarterly earnings results on Monday, January 29th. The company reported C($0.01) EPS for the quarter, meeting the consensus estimate of C($0.01). The business had revenue of C$2.69 million during the quarter, compared to analysts’ expectations of C$2.86 million.
Organigram Company Profile
OrganiGram Holdings Inc, through its subsidiary, Organigram Inc, produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.